Oktoscience
Secteur
Medtech
Description
Oktoscience is pioneering the development of smart, patient-specific implantable neuromodulation devices.
Our first product in development is a VNS (Vagus Nerve Stimulation) device intended to treat epilepsy. Indeed, VNS is a highly promising therapy for millions of epileptic patients in a therapeutic impasse. However, current implants have significant limitations, with a near 50% failure rate. The reason for this is that their electrical stimulation does not consider the individual physiological response of patients.
Oktoscience’ s proven technologies, protected by 7 patent families and based on 20 years of research, will overcome these limitations. They will lead to the design of an implant delivering patient-specific, closed-loop adaptive stimulation, opening the door to many clinical applications.
Type de levée de fonds
Seed
